Skip to Content

Sonova Holding AG SOON

Morningstar Rating
CHF 275.30 +3.00 (1.10%)
View Full Chart
Unlock our analysis with Morningstar Investor

Company Report

Hearing Market Continues to Rebound for Sonova

Sonova benefits from favorable trends, including an aging population, increasing noise pollution, fairly low penetration rates for hearing aids in the developed world, and virtually untapped patient populations in emerging markets. Its broad product offerings should allow the company to capitalize on these trends, while its strong brand and superior technological know-how should yield market share gains.

Price vs Fair Value

SOON is trading at a 2% premium.
Price
CHF 272.30
Fair Value
CHF 224.00
Uncertainty
Medium
1-Star Price
CHF 523.60
5-Star Price
CHF 242.80
Economic Moat
Fccplnd
Capital Allocation
Ylgrjkc

Bulls Say, Bears Say

Bulls

Premium products account for a significant portion of Sonova's total revenue, limiting the firm's dependence on price-sensitive economy-class systems.

Bears

WS Audiology (previously Sivantos and Widex) is regaining momentum, particularly in emerging markets. Its acquisition of Widex could threaten the positioning of premium providers.

Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if SOON is a good fit for your portfolio.

Trading Information

Previous Close Price
CHF 272.30
Day Range
CHF 270.60276.10
52-Week Range
CHF 205.80293.20
Bid/Ask
CHF 275.20 / CHF 275.40
Market Cap
CHF 16.41 Bil
Volume/Avg
63,602 / 141,558

Key Statistics

Price/Earnings (Normalized)
22.84
Price/Sales
4.47
Dividend Yield (Trailing)
1.69%
Dividend Yield (Forward)
1.69%
Total Yield
2.71%

Company Profile

Sonova is one of the world's largest manufacturers and distributors of hearing aids. The company is based in Switzerland and distributes its products in more than 100 countries through its internal sales team and independent retailers. It also sells cochlear implants through its advanced bionics subsidiary and recently acquired Sennheiser's consumer division to expand into audio technologies.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Large Core
Total Number of Employees
17,636

Competitors

Valuation

Metric
SOON
GN
DEMANT
Price/Earnings (Normalized)
22.8431.4630.51
Price/Book Value
7.692.458.22
Price/Sales
4.471.243.43
Price/Cash Flow
21.1210.1817.79
Price/Earnings
SOON
GN
DEMANT

Financial Strength

Metric
SOON
GN
DEMANT
Quick Ratio
0.760.480.84
Current Ratio
1.290.651.37
Interest Coverage
29.181.866.91
Quick Ratio
SOON
GN
DEMANT

Profitability

Metric
SOON
GN
DEMANT
Return on Assets (Normalized)
11.96%0.30%8.40%
Return on Equity (Normalized)
30.61%1.10%28.27%
Return on Invested Capital (Normalized)
22.85%1.28%12.19%
Return on Assets
SOON
GN
DEMANT
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
ABT
Abbott LaboratoriesQhgzrvx$205.9 Bil
SYK
Stryker CorpTbq$132.7 Bil
MDT
Medtronic PLCFzzt$110.7 Bil
BSX
Boston Scientific CorpSfkrzf$97.1 Bil
EW
Edwards Lifesciences CorpLpxlxt$51.0 Bil
DXCM
DexCom IncPcnqr$44.4 Bil
ZBH
Zimmer Biomet Holdings IncDbdr$25.5 Bil
ALGN
Align Technology IncJywzbnx$23.2 Bil
PHG
Koninklijke Philips NV ADRSpndng$18.2 Bil
SNN
Smith & Nephew PLC ADRLmjzvg$11.5 Bil

Sponsor Center